Lan Zhao

5.0k total citations
98 papers, 3.2k citations indexed

About

Lan Zhao is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Physiology. According to data from OpenAlex, Lan Zhao has authored 98 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Pulmonary and Respiratory Medicine, 33 papers in Cardiology and Cardiovascular Medicine and 23 papers in Physiology. Recurrent topics in Lan Zhao's work include Pulmonary Hypertension Research and Treatments (60 papers), Nitric Oxide and Endothelin Effects (15 papers) and Cardiovascular Function and Risk Factors (10 papers). Lan Zhao is often cited by papers focused on Pulmonary Hypertension Research and Treatments (60 papers), Nitric Oxide and Endothelin Effects (15 papers) and Cardiovascular Function and Risk Factors (10 papers). Lan Zhao collaborates with scholars based in United Kingdom, China and United States. Lan Zhao's co-authors include Martin R. Wilkins, Almaz Aldashev, Nicholas W. Morrell, Abdirashit Maripov, Baktybek Kojonazarov, М М Миррахимов, A. Sadykov, John Wharton, Emanuele Cotroneo and Olivier Dubois and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Circulation.

In The Last Decade

Lan Zhao

94 papers receiving 3.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lan Zhao United Kingdom 32 1.8k 1.1k 1.1k 694 314 98 3.2k
Xi‐Chen Wu Canada 20 1.1k 0.6× 1.1k 1.0× 736 0.7× 588 0.8× 174 0.6× 28 2.6k
Ayako Makino United States 39 1.2k 0.7× 1.8k 1.7× 847 0.8× 1.1k 1.6× 309 1.0× 106 4.0k
Yuansheng Gao United States 27 805 0.5× 783 0.7× 612 0.6× 1.1k 1.5× 146 0.5× 92 2.5k
Thomas C. Resta United States 33 1.1k 0.6× 1.0k 0.9× 505 0.5× 1.2k 1.7× 187 0.6× 96 2.9k
Václav Hampl Czechia 29 1.4k 0.8× 1.2k 1.1× 979 0.9× 1.7k 2.4× 185 0.6× 63 3.5k
Bernadette Raffestin France 33 3.1k 1.8× 775 0.7× 1.5k 1.5× 1.6k 2.3× 255 0.8× 75 4.4k
Peter Hansell Sweden 30 584 0.3× 1.1k 1.0× 472 0.4× 714 1.0× 275 0.9× 157 4.2k
Hiroshi Nonoguchi Japan 42 1.4k 0.8× 2.5k 2.3× 1.0k 1.0× 1.1k 1.7× 72 0.2× 144 5.2k
J. T. Sylvester United States 27 1.7k 1.0× 1.3k 1.2× 564 0.5× 1.2k 1.8× 656 2.1× 55 3.5k
Eddie L. Greene United States 28 491 0.3× 1.0k 0.9× 611 0.6× 411 0.6× 140 0.4× 63 2.8k

Countries citing papers authored by Lan Zhao

Since Specialization
Citations

This map shows the geographic impact of Lan Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lan Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lan Zhao more than expected).

Fields of papers citing papers by Lan Zhao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lan Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lan Zhao. The network helps show where Lan Zhao may publish in the future.

Co-authorship network of co-authors of Lan Zhao

This figure shows the co-authorship network connecting the top 25 collaborators of Lan Zhao. A scholar is included among the top collaborators of Lan Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lan Zhao. Lan Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ferreira, Eloara V.M., Rudolf K.F. Oliveira, Reinaldo Salomão, et al.. (2025). Early Use of Liraglutide for the Treatment of Acute COVID-19 Infection: An Open-Label Single-Center Phase II Safety Study with Biomarker Profiling. Infectious Disease Reports. 17(1). 5–5.
2.
Jiang, Yanan, Lan Zhao, Yankun Liu, et al.. (2025). An Integrated Multi‐Omics Analysis Reveals the Protective Mechanism of Aspirin on Metabolic Dysfunction‐Associated Steatotic Liver Disease. The FASEB Journal. 39(12). e70726–e70726. 1 indexed citations
3.
Sun, Zhaohui, et al.. (2025). Refining Reduced the Number and Content of Compounds of Soybean Oil. eFood. 6(1).
4.
Hao, Nan, et al.. (2023). Active ingredients of Chinese medicine with immunomodulatory properties: NF-κB pathway and Parkinson's disease. Brain Research. 1822. 148603–148603. 6 indexed citations
5.
Kirkby, Nicholas S., Ivan Diakonov, Peter Wright, et al.. (2023). Pulmonary Hypertension-Associated Right Ventricular Cardiomyocyte Remodelling Reduces Treprostinil Function. Cells. 12(23). 2764–2764. 1 indexed citations
6.
Green, Hannah L.H., Susanne Krasemann, Kristin Hartmann, et al.. (2023). Cyclin D-CDK4 Disulfide Bond Attenuates Pulmonary Vascular Cell Proliferation. Circulation Research. 133(12). 966–988. 14 indexed citations
7.
Liu, Lianhua, Jixiang Liu, Shiqing Xu, et al.. (2023). Inhibition of heterogeneous nuclear ribonucleoproteins A1 and oxidative stress reduces glycolysis via pyruvate kinase M2 in chronic thromboembolic pulmonary hypertension. Journal of Translational Internal Medicine. 12(4). 437–451. 3 indexed citations
8.
Hajji, Nabil, Sunniyat Rahman, John Wharton, et al.. (2023). Restoration of Foxp3+ Regulatory T Cells by HDAC-Dependent Epigenetic Modulation Plays a Pivotal Role in Resolving Pulmonary Arterial Hypertension Pathology. American Journal of Respiratory and Critical Care Medicine. 208(8). 879–895. 18 indexed citations
9.
Zhao, Lan, Weifeng Jiang, Chenxi Yang, et al.. (2021). SOX17 loss-of-function variation underlying familial congenital heart disease. European Journal of Medical Genetics. 64(5). 104211–104211. 12 indexed citations
10.
Gassmann, Max, Andrew S. Cowburn, Hong Gu, et al.. (2020). Hypoxia‐induced pulmonary hypertension—Utilizing experiments of nature. British Journal of Pharmacology. 178(1). 121–131. 21 indexed citations
11.
Baxan, Nicoleta, Lan Zhao, Isabelle Leclerc, et al.. (2020). Synthesis and in vivo behaviour of an exendin-4-based MRI probe capable of β-cell-dependent contrast enhancement in the pancreas. Dalton Transactions. 49(15). 4732–4740. 5 indexed citations
12.
Baxan, Nicoleta, Angelos Papanikolaou, Isabelle I. Salles‐Crawley, et al.. (2019). Characterization of acute TLR-7 agonist-induced hemorrhagic myocarditis in mice by multiparametric quantitative cardiac magnetic resonance imaging. Disease Models & Mechanisms. 12(8). 4 indexed citations
13.
Zhao, Jiali, Lan Zhao, Yanfeng Chen, et al.. (2019). The effects of zinc deficiency on homeostasis of twelve minerals and trace elements in the serum, feces, urine and liver of rats. Nutrition & Metabolism. 16(1). 73–73. 24 indexed citations
14.
Ashek, Ali, Onno A. Spruijt, Hendrik J. Harms, et al.. (2018). 3′-Deoxy-3′-[18F]Fluorothymidine Positron Emission Tomography Depicts Heterogeneous Proliferation Pathology in Idiopathic Pulmonary Arterial Hypertension Patient Lung. Circulation Cardiovascular Imaging. 11(8). e007402–e007402. 11 indexed citations
15.
Zhao, Lan, Ali Ashek, Lei Wang, et al.. (2013). Heterogeneity in Lung 18 FDG Uptake in Pulmonary Arterial Hypertension. Circulation. 128(11). 1214–1224. 109 indexed citations
16.
Zeng, Weijie, Changming Xiong, Lan Zhao, et al.. (2012). Atorvastatin in Pulmonary Arterial Hypertension (APATH) study. European Respiratory Journal. 40(1). 67–74. 50 indexed citations
17.
18.
Robbins, Ivan M., Anna R. Hemnes, J. Simon R. Gibbs, et al.. (2010). Safety of sapropterin dihydrochloride (6r–bh4) in patients with pulmonary hypertension. Experimental Lung Research. 37(1). 26–34. 36 indexed citations
19.
Baliga, Reshma S., Lan Zhao, Melanie Madhani, et al.. (2008). Synergy between Natriuretic Peptides and Phosphodiesterase 5 Inhibitors Ameliorates Pulmonary Arterial Hypertension. American Journal of Respiratory and Critical Care Medicine. 178(8). 861–869. 53 indexed citations
20.
Wang, Cong, Jun Wang, Lan Zhao, et al.. (2008). Sildenafil Inhibits Human Pulmonary Artery Smooth Muscle Cell Proliferation by Decreasing Capacitative Ca2+ Entry. Journal of Pharmacological Sciences. 108(1). 71–78. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xi‐Chen Wu Breakdown of academic impact, for papers by Ayako Makino Breakdown of academic impact, for papers by Yuansheng Gao Breakdown of academic impact, for papers by Thomas C. Resta Breakdown of academic impact, for papers by Václav Hampl Breakdown of academic impact, for papers by Bernadette Raffestin Breakdown of academic impact, for papers by Peter Hansell Breakdown of academic impact, for papers by Hiroshi Nonoguchi Breakdown of academic impact, for papers by J. T. Sylvester Breakdown of academic impact, for papers by Eddie L. Greene
Rankless by CCL
2026